| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/03/2011 | US20110028383 Activated Forms Of Notch And Methods Based Thereon |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027390 Methods for Reducing Cisplatin Nephrotoxicity |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027379 Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027375 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 02/03/2011 | US20110027374 Capecitabine rapidly disintegrating tablets |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027322 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy |
| 02/03/2011 | US20110027310 Compositions and Methods for Cancer Treatment |
| 02/03/2011 | US20110027303 Partial peptide of survivin presented on mhc class ii molecule and use therof |
| 02/03/2011 | US20110027302 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing |
| 02/03/2011 | US20110027296 Antibodies for treating cancer |
| 02/03/2011 | US20110027295 Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses |
| 02/03/2011 | US20110027291 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response |
| 02/03/2011 | US20110027289 Method for treating synovial sarcoma |
| 02/03/2011 | US20110027286 High Affinity Human Antibodies to Human Angiopoietin-2 |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027283 Methods for diagnosing and treating cancers |
| 02/03/2011 | US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027276 Optimized CD40 Antibodies and Methods of Using the Same |
| 02/03/2011 | US20110027275 Inhibition of tumor metastasis |
| 02/03/2011 | US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 02/03/2011 | US20110027268 Anti-mesothelin antibodies and uses thereof |
| 02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
| 02/03/2011 | US20110027259 Component of bromelain |
| 02/03/2011 | US20110027255 Composition and Method for Treating Papilloma Virus and Equine Sarcoids |
| 02/03/2011 | US20110027247 Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme q10) |
| 02/03/2011 | US20110027245 Pairing processes for preparing alloreactive cytotoxic T cells |
| 02/03/2011 | US20110027244 Compositions and methods of preparing alloreactive cytotoxic T cells |
| 02/03/2011 | US20110027239 Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer |
| 02/03/2011 | US20110027238 Mesenchymal Stem Cells and Uses Therefor |
| 02/03/2011 | US20110027228 Uses of interferons with altered spatial structure |
| 02/03/2011 | US20110027226 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/03/2011 | US20110027225 MN/CA IX and EGFR Pathway Inhibition |
| 02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
| 02/03/2011 | US20110027190 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/03/2011 | US20110027186 Taz/wwtr1 for diagnosis and treatment of cancer |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027180 Detection and treatment of prostate cancer |
| 02/03/2011 | US20110027179 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 02/03/2011 | US20110027177 Inhibition of angiogenesis |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | US20110027174 Nanotubes for cancer therapy and diagnostics |
| 02/03/2011 | US20110027173 Ephrin type-a receptor 10 protein |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 02/03/2011 | DE102009035586A1 Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs Intravesical instillation to treat bladder cancer |
| 02/03/2011 | CA2769765A1 Polymorphic form of toremifene citrate and process for its preparation |
| 02/03/2011 | CA2769754A1 Folate-targeted diagnostics and treatment |
| 02/03/2011 | CA2769633A1 Crystallization method and bioavailability |
| 02/03/2011 | CA2769624A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | CA2769531A1 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
| 02/03/2011 | CA2769477A1 Pharmaceutical formulation |
| 02/03/2011 | CA2769349A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process |
| 02/03/2011 | CA2769334A1 High affinity human antibodies to human angiopoietin-2 |
| 02/03/2011 | CA2769308A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | CA2769298A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | CA2769209A1 Pyrrolo [1,2-b] pyridazine derivatives as janus kinase inhibitors |
| 02/03/2011 | CA2769203A1 Liver x receptor agonists |
| 02/03/2011 | CA2769161A1 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | CA2769038A1 Antiangiogenic small molecules and methods of use |
| 02/03/2011 | CA2768821A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2768286A1 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer |
| 02/03/2011 | CA2768086A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2767875A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 02/03/2011 | CA2767767A1 Compositions for generating an antigen specific immune response |
| 02/03/2011 | CA2767066A1 Pyridine and pyrazine derivatives as protein kinase modulators |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280022A1 Cripto blocking molecules and therapeutic uses thereof |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280011A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2 |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279999A1 Retinoid derivative and pharmaceutical composition and use thereof |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279254A1 Novel lipid formulations for nucleic acid delivery |
| 02/02/2011 | EP2279253A2 Engineering and delivery of therapeutic compositions of freshly isolated cells |
| 02/02/2011 | EP2279199A1 Peptide homing to brain tumors |
| 02/02/2011 | EP2279197A1 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| 02/02/2011 | EP2279196A2 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/02/2011 | EP2279195A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 02/02/2011 | EP2279193A1 Novel triazole derivatives, their preparation and their application in therapeutics |
| 02/02/2011 | EP2279188A1 Purine pi3k inhibitor compounds and methods of use |
| 02/02/2011 | EP2279187A1 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/02/2011 | EP2279176A1 Novel imidazole derivatives having microbiocidal activity |
| 02/02/2011 | EP2279174A2 Arylsulfonamide compounds, compositions and methods of use |